Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?
Authors:
- Takayuki MikiTMTakayuki Miki
- Toshiyuki TobisawaTTToshiyuki Tobisawa
- Tatsuya SatoTatsuya Sato
- Masaya TannoMTMasaya Tanno
- Toshiyuki YanoTYToshiyuki Yano
- Hiroshi AkasakaHAHiroshi Akasaka
- Atsushi KunoAKAtsushi Kuno
- Makoto OgasawaraMOMakoto Ogasawara
- Hiromichi MuraseHMHiromichi Murase
- Shigeyuki SaitohSSShigeyuki Saitoh
- Tetsuji MiuraTMTetsuji Miura
Open Access
- 21 August 2014
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 13 (1) , 1-10
Abstract
Abnormal ventricular repolarization is a predictor of cardiovascular mortality. In this study, we tested the hypothesis that glycemic control reverses abnormal ventricular repolarization in patients with type 2 diabetes. We analyzed longitudinal changes in repolarization indices of electrocardiograms in retrospectively enrolled 44 patients with type 2 diabetes and 44 age-matched healthy subjects. In the diabetic group, BMI was greater, levels of HbA1c (10.0 ± 1.6 vs. 5.6 ± 0.3%) and triglyceride were higher and level of HDL cholesterol was lower than those in the control group. Although mean QTc intervals were similar (413.6 ± 18.5 vs. 408.3 ± 22.7 ms), QT dispersion (41.8 ± 15.4 vs. 28.7 ± 7.7 ms) and Tpeak-Tend in lead V5 (83.6 ± 13.6 vs. 71.3 ± 10.3 ms) were significantly longer in the diabetic group than in the control group, indicating increased heterogeneity of ventricular repolarization in type 2 diabetes. During follow-up of 36 patients in the diabetic group for 787 ± 301 days, HbA1c level decreased to 7.3 ± 1.6%, while BMI did not significantly change. In contrast to HbA1c, QT dispersion (45.8 ± 15.0 ms) and Tpeak-Tend in lead V5 (83.6 ± 10.6 ms) were not significantly reduced during the follow-up period. There was no correlation between the change in HbA1c and the change in QT dispersion or Tpeak-Tend. Increased heterogeneity of ventricular repolarization in type 2 diabetic patients was not reduced during the relatively short follow-up period despite significantly improved glycemic control.Keywords
This publication has 47 references indexed in Scilit:
- The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) studyCardiovascular Diabetology, 2013
- Diabetic cardiomyopathy: pathophysiology and clinical featuresHeart Failure Reviews, 2012
- Electrocardiographic QT Interval and MortalityEpidemiology, 2011
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- Tpeak-Tend and Tpeak-Tend Dispersion as Risk Factors for Ventricular Tachycardia/Ventricular Fibrillation in Patients With the Brugada SyndromeJACC, 2006